Acticor Biotech acticor-biotech.com


Acticor Biotech is developing an anti-thrombotic agent without bleeding risk for the emergency treatment of ischemic strokes. Its ACT-017 inhibits a new target protein, the glycoprotein VI, which is specifically responsible for the growth of blood clots during a stroke.

Acticor Biotech is developing an anti-thrombotic agent without bleeding risk for the emergency treatment of ischemic strokes. Its ACT-017 inhibits a new target protein, the glycoprotein VI, which is specifically responsible for the growth of blood cl...Show all

Company (Alive / Active)

Phone: +33 970 468 640

Fax:

Batiment Inserm U1148, Hopital Bichat, secteur Claude Bernard
46 rue Henri Huchard
Paris, 75877
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Acticor Biotech $22.8M Oct 17, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Acticor Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)